950 — Lee's Pharmaceutical Holdings Share News
0.000.00%
Last trade - 00:00- HK$624.17m
- HK$330.52m
- HK$1.44bn
Brief: Lee's Pharma Says Zhaoke (Hk) Ophthalmology Pharma & Nevakar Entered Licensing Agreement
Brief: Lee's Pharmaceutical Says Unit To Advance Powder Pharmaceuticals Inc Additional Loan Of HK$15 Million
Brief: Lee's Pharmaceutical Says Phase III Trial Of Staccato Loxapine Meets Primary Endpoint
Brief: Lee's Pharmaceutical Says Investigational NDA Of Staccato Fentanyl Accepted By NMPA
Brief: Lee's Pharmaceutical Holdings - QTRLY Revenue HK$283.7 Mln Versus HK$324.6 Mln
Brief: Lee's Pharmaceutical Holdings Sees Increase in HY Unaudited Net Profit
Brief: Lee's Pharmaceutical Says Unit's Nadroparin Calcium For Injection Obtained Drug Registration Approval
Brief: Lee's Pharmaceutical Says Unit To Advance Loan In Principal Amount Of US$5.0 Mln
Brief: Lee's Pharmaceutical Holdings Says Considering Possible Spin-Off And Separate Listing Of Shares Of Unit
Brief: Lee's Pharmaceutical Says On 25 June, Unit & Panoptica Entered Binding Letter Of Intent
Brief: Lee's Pharmaceutical Says Unit Obtained Imported Drug License For Unidrox From China's NMPA
Brief: Lee's Pharmaceutical Updates On Trial Of Adapalene-Clindamycin Combination Gel In China
Brief: Lee's Pharmaceutical Posts QTRLY Profit Attributable Hk$39.9 Million
Brief: Lee's Pharmaceutical Holdings Announces Provision Of Financial Assistance
Brief: Lee's Pharmaceutical Says Unit's New Drug Application Of Natulan Accepted For Review
Brief: Lee's Pharmaceutical Says Unit Entered Binding LOI
Brief: Lee's Pharmaceutical Holdings Says Unit To Provide Loan In Principal Amount Of US$2 Mln
Brief: Lee's Pharmaceutical Holdings Posts FY Profit Attributable Of HK$125.6 Mln
Brief: Lee's Pharmaceutical Says Lee's Int'l To Advance Shareholder Loan Of HK$8 Mln To PPI